LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma

NOTCH1 Intracellular Domain Immunohistochemistry as a Diagnostic Tool to Distinguish T-Lymphoblastic Lymphoma From Thymoma

(2015) Armin G. Jegalian et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia

(2015) L. Wu et al.   HAEMATOLOGICA

Diagnostic Utility of the Germinal Center–associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms

(2015) Thomas Menter et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia

(2015) L. Wu et al.   HAEMATOLOGICA

LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways

(2014) Stephen Smith et al.   PLoS One

Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody

(2012) Claudio Agostinelli et al.   HISTOPATHOLOGY

The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal

(2010) M. P. McCormack et al.   SCIENCE